A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People
Clinical trial NCT05050279 · COMPLETED
Trial details
- NCT number
- NCT05050279
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-29
- Primary completion
- 2022-01-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.